ArticlePloS one2025
XLLC-Net: A lightweight and explainable CNN for accurate lung cancer classification using histopathological images.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinical validation of lightweight CNN architectures for reliable multi-class classification of lung cancer using histopathological imaging techniques.Scientific reports · 2026Article
- Compact deep learning models for colon histopathology focusing performance and generalization challenges.Scientific reports · 2026Article
- EGFR Mutation Detection in Whole Slide Images of Non-Small Cell Lung Cancers Using a Two-Stage Deep Transfer Learning Approach.Cancer medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer imaging plays a crucial role in early diagnosis and treatment, where machine learning and deep learning have significantly advanced the accuracy and efficiency of disease classification. This study introduces the Explainable and Lightweight Lung Cancer Net (XLLC-Net), a streamlined convolutional neural network designed for classifying lung cancer from histopathological images. Using the LC25000 dataset, which includes three lung cancer classes and two colon cancer classes, we focused solely on the three lung cancer classes for this study. XLLC-Net effectively discerns complex disease patterns within these classes. The model consists of four convolutional layers and contains merely 3 million parameters, considerably reducing its computational footprint compared to existing deep learning models. This compact architecture facilitates efficient training, completing each epoch in just 60 seconds. Remarkably, XLLC-Net achieves a classification accuracy of 99.62% [Formula: see text] 0.16%, with precision, recall, and F1 score of 99.33% [Formula: see text] 0.30%, 99.67% [Formula: see text] 0.30%, and 99.70% [Formula: see text] 0.30%, respectively. Furthermore, the integration of Explainable AI techniques, such as Saliency Map and GRAD-CAM, enhances the interpretability of the model, offering clear visual insights into its decision-making process. Our results underscore the potential of lightweight DL models in medical imaging, providing high accuracy and rapid training while ensuring model transparency and reliability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.